| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | A randomized trial of exemestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancer. | N Engl J Med | 2004 | 10.41 |
| 2 | Survival and safety of exemestane versus tamoxifen after 2-3 years' tamoxifen treatment (Intergroup Exemestane Study): a randomised controlled trial. | Lancet | 2007 | 8.08 |